For the Inventor, By the Inventor

Enter inventor name

Rehovot, Israel

Abraham Nudelman

USPTO Granted Patents = 45 (Patent Applications = 10)

EPO Patents = 7 (Patent Applications = 4)

Average Co-Inventor Count = 2.6

ph-index = 11

Forward Citations = 445(Granted Patents)

Location History:

Rehovot, IL (1978 - 2016)
Rechovot, IL (2009 - 2016)

Company Filing History:

Bar-ilan University

16 out of 1,168

Yeda Research and Develpment & Co. Ltd

Tel Aviv University

4. 6 out of 102

Mor Research Applications Ltd.

Beacon Laboratories, Inc.

Kupat Holim Health Insurance Institution of the General Federation of

Kupat Holim Health Institution of the General Federation of Labor

Bar-ilan Research & Development Co., Ltd.

10. 1 out of 893

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

11. 2 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 1978-2016

Loading Chart...

Loading Chart...

Areas of Expertise:

Indole Derivatives

Purinic Antiviral Agents

Cognitive Function Improvement

Neurodegenerative Disease Treatment

GABA Agonists

Psychotropic Drug Conjugates

Oxyalkylene Esters

Carboxylic Acid Esters

Cephalosporin Derivatives

Penicillin Derivatives

Podophyllotoxin Derivatives

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9499484 - Indole, indoline derivatives, compositions comprising them and uses thereof (2016-11-22),

2. 9334272 - Derivatives of purinic and pyrimidinic antiviral agents and use thereof as potent anticancer agents (2016-05-10),

3. 9018257 - 5-aminolevulinic acid derivatives, methods for their preparation and uses thereof (2015-04-28),

4. 8975251 - Methods of improving cognitive functions (2015-03-10),

5. 8916610 - Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same (2014-12-23),

6. 8722923 - Conjugates for treating neurodegenerative diseases and disorders (2014-05-13),

7. 8377990 - Conjugates comprising a psychotropic drug or a GABA agonist and an organic acid and their use in treating pain and other CNS disorders (2013-02-19),

8. 8377929 - Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same (2013-02-19),

9. 8283381 - Conjugated psychotropic drugs and uses thereof (2012-10-09),

10. 8222296 - Conjugates comprising a GABA- or glycine compound, pharmaceutical compositions and combinations thereof and their use in treating CNS disorders (2012-07-17),

11. 8207369 - Conjugates for treating neurodegenerative diseases and disorders (2012-06-26),

12. 8168628 - Conjugated psychotropic drugs and uses thereof (2012-05-01),

13. 7939525 - Conjugated psychotropic drugs and uses thereof (2011-05-10),

14. 7619006 - Conjugated psychotropic drugs and uses thereof (2009-11-17),

15. 7598239 - Conjugated psychotropic drugs and uses thereof (2009-10-06),

Title: Abraham Nudelman: A Pioneering Innovator in Biomedical Technology

Introduction

Abraham Nudelman, based in Rehovot, Israel, is a notable inventor with an impressive portfolio of 29 patents. His work primarily focuses on advancements in the biomedical field, particularly in developing innovative methods and compositions for treating various medical conditions.

Latest Patents

Nudelman's recent patents highlight his groundbreaking contributions to medicine. One of his notable inventions, "Uses of hydroxy and ether-containing oxyalkylene esters for treating metabolic conditions," encompasses compositions and methods aimed at treating, preventing, or ameliorating cancer and other proliferative diseases. These innovative methods also include applications for wound healing, gastrointestinal disorders, and immunomodulation, among others. Another significant invention, "Tricarboxylic acid-containing oxyalkyl esters and uses thereof," similarly addresses treatments for cancer and other conditions, focusing on enhancing recombinant gene expression and inducing tolerance to antigens.

Career Highlights

Throughout his career, Abraham Nudelman has collaborated with esteemed institutions and organizations. He has been associated with Yeda Research and Development Company and Bar-Ilan University, where he contributed to research and development initiatives. His extensive experience in the field showcases his commitment to advancing healthcare technology.

Collaborations

Nudelman's career has been enriched by collaborations with notable professionals, including Abraham Patchornik and Ada Rephaeli. These partnerships have facilitated the development of innovative solutions in the biomedical sector, underscoring the importance of teamwork in scientific advancements.

Conclusion

Abraham Nudelman stands out as a significant figure in the realm of biomedical innovations. His 29 patents not only reflect his inventiveness but also his dedication to improving medical treatments. As he continues to push the boundaries of research and development, his contributions will undoubtedly impact the future of healthcare positively.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…